1. Apoptosis Anti-infection NF-κB MAPK/ERK Pathway
  2. Apoptosis Virus Protease NF-κB p38 MAPK JNK Caspase
  3. Angelicin

Angelicin is a furanocoumarin compound that functions as an inhibitor of NF-κB and MAPK signaling pathways, exhibiting anti-inflammatory, antiviral, and antitumor activities. It suppresses the lytic replication of γ-herpesviruses, such as MHV-68, early during viral infection, potentially inhibiting RTA gene expression (IC50=28.95 μM). Angelicin also mitigates inflammation by inhibiting the phosphorylation and nuclear translocation of NF-κB, and the phosphorylation of p38 and JNK. Furthermore, it induces apoptosis in neuroblastoma cells by downregulating anti-apoptotic proteins like Bcl-2, Bcl-xL, and Mcl-1, while activating caspase-9 and caspase-3.

For research use only. We do not sell to patients.

CAS No. : 523-50-2

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 11 publication(s) in Google Scholar

Other Forms of Angelicin:

Top Publications Citing Use of Products

    Angelicin purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2021 Jun 9:12:669213.  [Abstract]

    Effect of angelicin on the cell viability of BMM. The cytotoxic effects of Angelicin (10, 20, 30, 50, 100 μmol/L) were detected at the different concentrations for 24 and 48 h using CCK-8 assay.

    Angelicin purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2021 Jun 9:12:669213.  [Abstract]

    Representative image of apoptosis rate detected by flow cytometry treated with Angelicin (10, 20, 30, 50, 100 μmol/L).

    Angelicin purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2021 Jun 9:12:669213.  [Abstract]

    Western blot analysis of iNOS, Arg-1, STAT3, p-STAT3, and β-actin in BMMs treated with LPS, LPS + Angelicin (ANG) (30 μM), LPS + IL-4/IL-13 + Angelicin + AG490.

    Angelicin purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2021 Jun 9:12:669213.  [Abstract]

    qRT-PCR assay of IL-1β and TNF-α expression in BMMs treated with Angelicin (ANG).(30 μM).

    Angelicin purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2021 Jun 9:12:669213.  [Abstract]

    ELISA for IL-1β and TNF-α concentration from cellular supernatant treated with Angelicin (ANG).(30 μM).
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Angelicin is a furanocoumarin compound that functions as an inhibitor of NF-κB and MAPK signaling pathways, exhibiting anti-inflammatory, antiviral, and antitumor activities. It suppresses the lytic replication of γ-herpesviruses, such as MHV-68, early during viral infection, potentially inhibiting RTA gene expression (IC50=28.95 μM). Angelicin also mitigates inflammation by inhibiting the phosphorylation and nuclear translocation of NF-κB, and the phosphorylation of p38 and JNK. Furthermore, it induces apoptosis in neuroblastoma cells by downregulating anti-apoptotic proteins like Bcl-2, Bcl-xL, and Mcl-1, while activating caspase-9 and caspase-3.

    IC50 & Target

    Caspase-9

     

    Caspase-3

     

    Cellular Effect
    Cell Line Type Value Description References
    A549 IC50
    > 10 3
    Compound: 21
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    [PMID: 25710081]
    A549 IC50
    > 10 3
    Compound: 21
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    [PMID: 25710081]
    A549 IC50
    >10 3
    Compound: 21
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    [PMID: 25710081]
    HL-60 IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    HL-60 GI50
    1.2 3
    Compound: Ang
    Photocytotoxicity against human HL60 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human HL60 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    HL-60 IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HL-60 IC50
    1.2 3
    Compound: Angelicin
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line at 2.5 joule/cm**2 UVA dose
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line at 2.5 joule/cm**2 UVA dose
    [PMID: 15837311]
    HL-60 IC50
    0.9 3
    Compound: Angelicin
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line at 3.2 joule/cm**2 UVA dose
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line at 3.2 joule/cm**2 UVA dose
    [PMID: 15837311]
    HL-60 IC50
    1.2 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    HL-60 GI50
    1.2 3
    Compound: Ang
    Photocytotoxicity against human HL60 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human HL60 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    HL-60 IC50
    16 3
    Compound: 2
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line; Range 0.4-16 uM
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line; Range 0.4-16 uM
    [PMID: 15837311]
    HL-60 IC50
    1.2 3
    Compound: 2, ANG
    Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HL-60 IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HL-60 IC50
    1.2 3
    Compound: 2, ANG
    Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HL-60 GI50
    1.2 3
    Compound: Ang
    Photocytotoxicity against human HL60 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human HL60 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    HL-60 IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    HT-1080 IC50
    15.7 3
    Compound: 2, ANG
    Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HL-60 IC50
    0.9 3
    Compound: Angelicin
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line at 3.2 joule/cm**2 UVA dose
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line at 3.2 joule/cm**2 UVA dose
    [PMID: 15837311]
    HL-60 IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HT-1080 IC50
    15.7 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    HL-60 IC50
    1.2 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    HL-60 IC50
    1.2 3
    Compound: 2, ANG
    Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HT-1080 IC50
    2.5 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    HL-60 IC50
    1.2 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    HL-60 IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    HT-1080 IC50
    15.7 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    HT-1080 IC50
    2.6 3
    Compound: 2, ANG
    Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HL-60 IC50
    1.2 3
    Compound: Angelicin
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line at 2.5 joule/cm**2 UVA dose
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line at 2.5 joule/cm**2 UVA dose
    [PMID: 15837311]
    HT-1080 IC50
    2.6 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    HT-1080 IC50
    2.6 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    HL-60 IC50
    16 3
    Compound: 2
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line; Range 0.4-16 uM
    Cytotoxicity against HL-60 (human fibrosarcoma) cell line; Range 0.4-16 uM
    [PMID: 15837311]
    HT-1080 IC50
    2.5 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    Jurkat IC50
    > 20 3
    Compound: 2, Ang
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    [PMID: 19230658]
    HT-1080 IC50
    15.7 3
    Compound: 2, ANG
    Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HT-1080 IC50
    15.7 3
    Compound: 2, ANG
    Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    Jurkat IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    [PMID: 21397509]
    HT-1080 IC50
    15.7 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    Jurkat IC50
    0.9 3
    Compound: Ang
    Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    HT-1080 IC50
    2.6 3
    Compound: 2, ANG
    Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HT-1080 IC50
    2.5 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    Jurkat GI50
    1 3
    Compound: Ang
    Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    Jurkat IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    HT-1080 IC50
    2.6 3
    Compound: 2, ANG
    Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    Jurkat IC50
    >20 3
    Compound: 2, Ang
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    [PMID: 19230658]
    Jurkat IC50
    0.9 3
    Compound: 2, Ang
    Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    HT-1080 IC50
    2.6 3
    Compound: Angelicin
    Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT1080 human fibrosarcoma cell line
    Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT1080 human fibrosarcoma cell line
    [PMID: 12873520]
    Jurkat IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    Jurkat IC50
    1 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    [PMID: 21397509]
    Jurkat IC50
    1 3
    Compound: Ang
    Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    Jurkat IC50
    0.9 3
    Compound: 2, Ang
    Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    Jurkat GI50
    1 3
    Compound: Ang
    Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    Jurkat IC50
    1 3
    Compound: Ang
    Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    K562 IC50
    > 10 3
    Compound: 21
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    [PMID: 25710081]
    Jurkat IC50
    0.9 3
    Compound: Ang
    Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    Jurkat IC50
    1 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    [PMID: 21397509]
    K562 IC50
    > 20 3
    Compound: 2, Ang
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    [PMID: 19230658]
    Jurkat IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    [PMID: 21397509]
    K562 IC50
    1 3
    Compound: Ang
    Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    K562 IC50
    1.2 3
    Compound: Ang
    Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    K562 IC50
    >10 3
    Compound: 21
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    [PMID: 25710081]
    K562 IC50
    >20 3
    Compound: 2, Ang
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    [PMID: 19230658]
    LoVo IC50
    > 20 3
    Compound: 2, Ang
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    [PMID: 19230658]
    K562 IC50
    1.2 3
    Compound: Ang
    Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    LoVo IC50
    0.9 3
    Compound: 2, Ang
    Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    K562 IC50
    1 3
    Compound: Ang
    Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo GI50
    4 3
    Compound: Ang
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    LoVo IC50
    1.1 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    [PMID: 21397509]
    LoVo GI50
    1.11 3
    Compound: Ang
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    LoVo GI50
    1.11 3
    Compound: Ang
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    LoVo IC50
    >20 3
    Compound: 2, Ang
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    [PMID: 19230658]
    LoVo IC50
    1.5 3
    Compound: Ang
    Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo IC50
    1.6 3
    Compound: Angelicin
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 2.5 joule/cm**2 UVA dose
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 2.5 joule/cm**2 UVA dose
    [PMID: 15837311]
    LoVo IC50
    1.6 3
    Compound: 2, ANG
    Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    Jurkat GI50
    1 3
    Compound: Ang
    Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    LoVo IC50
    1.6 3
    Compound: 2, Ang
    Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    LoVo IC50
    0.9 3
    Compound: Angelicin
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 3.2 joule/cm**2 UVA dose
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 3.2 joule/cm**2 UVA dose
    [PMID: 15837311]
    Jurkat IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    LoVo IC50
    0.8 3
    Compound: Angelicin
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 6.5 joule/cm**2 UVA dose
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 6.5 joule/cm**2 UVA dose
    [PMID: 15837311]
    LoVo IC50
    3.6 3
    Compound: Ang
    Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    Jurkat IC50
    0.9 3
    Compound: 2, Ang
    Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    LoVo IC50
    16 3
    Compound: 2
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line; Range 0.4-16 uM
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line; Range 0.4-16 uM
    [PMID: 15837311]
    LoVo IC50
    4 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    [PMID: 21397509]
    Jurkat IC50
    0.9 3
    Compound: Ang
    Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo IC50
    1.6 3
    Compound: 2, ANG
    Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    LoVo GI50
    4 3
    Compound: Ang
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    Jurkat IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    [PMID: 21397509]
    LoVo IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    MCF7 IC50
    1.5 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    Jurkat IC50
    1 3
    Compound: Ang
    Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    MCF7 IC50
    1.5 3
    Compound: Ang
    Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo IC50
    1.6 3
    Compound: 2, Ang
    Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    Jurkat IC50
    1 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
    [PMID: 21397509]
    MCF7 GI50
    1.5 3
    Compound: Ang
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    LoVo IC50
    0.9 3
    Compound: 2, Ang
    Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    Jurkat IC50
    > 20 3
    Compound: 2, Ang
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    [PMID: 19230658]
    MCF7 IC50
    4.4 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    LoVo IC50
    3.6 3
    Compound: Ang
    Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    K562 IC50
    1 3
    Compound: Ang
    Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo IC50
    1.5 3
    Compound: Ang
    Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    MCF7 IC50
    4.4 3
    Compound: Ang
    Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    K562 IC50
    1.2 3
    Compound: Ang
    Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    MCF7 GI50
    4.42 3
    Compound: Ang
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    K562 IC50
    > 10 3
    Compound: 21
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    [PMID: 25710081]
    LoVo IC50
    4 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    [PMID: 21397509]
    NCTC-2544 IC50
    > 20 3
    Compound: 2, Ang
    Cytotoxicity against human NCTC-2544 cells after 72 hrs by MTT assay
    Cytotoxicity against human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 19230658]
    LoVo IC50
    1.1 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    [PMID: 21397509]
    K562 IC50
    > 20 3
    Compound: 2, Ang
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    [PMID: 19230658]
    NCTC-2544 IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    MCF7 GI50
    4.42 3
    Compound: Ang
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    LoVo GI50
    1.11 3
    Compound: Ang
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    MCF7 GI50
    1.5 3
    Compound: Ang
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    NCTC-2544 IC50
    0.9 3
    Compound: Ang
    Phototoxicity against human sNCTC-2544 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human sNCTC-2544 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo GI50
    4 3
    Compound: Ang
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    MCF7 IC50
    4.4 3
    Compound: Ang
    Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    NCTC-2544 IC50
    1.5 3
    Compound: 2, ANG
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    LoVo IC50
    0.8 3
    Compound: Angelicin
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 6.5 joule/cm**2 UVA dose
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 6.5 joule/cm**2 UVA dose
    [PMID: 15837311]
    MCF7 IC50
    1.5 3
    Compound: Ang
    Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    NCTC-2544 IC50
    4.2 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    LoVo IC50
    0.9 3
    Compound: 2, ANG
    Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    MCF7 IC50
    4.4 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    NCTC-2544 IC50
    4.2 3
    Compound: Ang
    Phototoxicity against human sNCTC-2544 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human sNCTC-2544 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo IC50
    0.9 3
    Compound: 2, Ang
    Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    MCF7 IC50
    1.5 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    NCTC-2544 IC50
    4.2 3
    Compound: 2, ANG
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    LoVo IC50
    0.9 3
    Compound: Angelicin
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 3.2 joule/cm**2 UVA dose
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 3.2 joule/cm**2 UVA dose
    [PMID: 15837311]
    NCTC-2544 IC50
    >20 3
    Compound: 2, Ang
    Cytotoxicity against human NCTC-2544 cells after 72 hrs by MTT assay
    Cytotoxicity against human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 19230658]
    NCTC-2544 IC50
    4.2 3
    Compound: 2, Ang
    Phototoxicity against human NCTC-2544 cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human NCTC-2544 cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    LoVo IC50
    1.1 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    [PMID: 21397509]
    NCTC-2544 IC50
    4.2 3
    Compound: 2, ANG
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    LoVo IC50
    1.5 3
    Compound: Ang
    Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    NCTC-2544 IC50
    1.5 3
    Compound: 2, ANG
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    LoVo IC50
    1.6 3
    Compound: 2, ANG
    Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    LoVo IC50
    1.6 3
    Compound: 2, Ang
    Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    NCTC-2544 IC50
    4.2 3
    Compound: 2, Ang
    Phototoxicity against human NCTC-2544 cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human NCTC-2544 cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    LoVo IC50
    1.6 3
    Compound: Angelicin
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 2.5 joule/cm**2 UVA dose
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line at 2.5 joule/cm**2 UVA dose
    [PMID: 15837311]
    NCTC-2544 IC50
    4.2 3
    Compound: Ang
    Phototoxicity against human sNCTC-2544 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human sNCTC-2544 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    NCTC-2544 IC50
    0.9 3
    Compound: Ang
    Phototoxicity against human sNCTC-2544 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human sNCTC-2544 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    LoVo IC50
    16 3
    Compound: 2
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line; Range 0.4-16 uM
    Cytotoxicity against LoVo (human intestinal adenocarcinoma) cell line; Range 0.4-16 uM
    [PMID: 15837311]
    NCTC-2544 IC50
    4.2 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    LoVo IC50
    3.6 3
    Compound: Ang
    Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    NCTC-2544 IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    LoVo IC50
    4 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
    [PMID: 21397509]
    LoVo IC50
    > 20 3
    Compound: 2, Ang
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    [PMID: 19230658]
    MCF7 GI50
    1.5 3
    Compound: Ang
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    MCF7 GI50
    4.42 3
    Compound: Ang
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
    [PMID: 26295175]
    MCF7 IC50
    1.5 3
    Compound: Ang
    Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    MCF7 IC50
    1.5 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    MCF7 IC50
    4.4 3
    Compound: Ang
    Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    MCF7 IC50
    4.4 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    NCTC-2544 IC50
    0.9 3
    Compound: Ang
    Phototoxicity against human sNCTC-2544 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human sNCTC-2544 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    NCTC-2544 IC50
    0.9 3
    Compound: Ang
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    Phototoxicity in 3.75 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    NCTC-2544 IC50
    1.5 3
    Compound: 2, ANG
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    NCTC-2544 IC50
    4.2 3
    Compound: 2, ANG
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
    [PMID: 18951030]
    NCTC-2544 IC50
    4.2 3
    Compound: 2, Ang
    Phototoxicity against human NCTC-2544 cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    Phototoxicity against human NCTC-2544 cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
    [PMID: 19230658]
    NCTC-2544 IC50
    4.2 3
    Compound: Ang
    Phototoxicity against human sNCTC-2544 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    Phototoxicity against human sNCTC-2544 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
    [PMID: 20627596]
    NCTC-2544 IC50
    4.2 3
    Compound: Ang
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    Phototoxicity in 2.5 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 21397509]
    NCTC-2544 IC50
    > 20 3
    Compound: 2, Ang
    Cytotoxicity against human NCTC-2544 cells after 72 hrs by MTT assay
    Cytotoxicity against human NCTC-2544 cells after 72 hrs by MTT assay
    [PMID: 19230658]
    In Vitro

    Angelicin (30-50 μM; 48 h) induced apoptosis in SH-SY5Y cells, causing downregulation of Bcl-2, Bcl-xL, and Mcl-1 protein expression, and activated the cleavage of caspase-9 and caspase-3, leading to apoptosis[1].
    Angelicin (28.95 μM; 48 h) inhibited viral replication in MHV-68-infected BHK21 cells, causing downregulation of viral proteins ORF45 and ORF65 expression, and reduced viral genome replication and RTA mRNA expression[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Angelicin (1, 5, 10 mg/kg; intraperitoneal injection; once, 1 hour before LPS induction) shows anti-inflammatory effects in the LPS-induced acute lung injury model in mice, reducing inflammatory cell infiltration and cytokine production by inhibiting the MAPK and NF-κB pathways[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: LPS-induced acute lung injury BALB/c mouse model[3]
    Dosage: 1, 5, 10 mg/kg
    Administration: ip
    Result: Reduced the number of inflammatory cells, lung wet-to-dry weight ratio, MPO activity, reduced TNF-α and IL-6 levels, and improved lung tissue pathological changes.
    Molecular Weight

    186.16

    Formula

    C11H6O3

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C1C=CC2=CC=C(OC=C3)C3=C2O1

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 2 years
    -20°C 1 year
    Solvent & Solubility
    In Vitro: 

    DMSO : 33.33 mg/mL (179.04 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 5.3717 mL 26.8586 mL 53.7172 mL
    5 mM 1.0743 mL 5.3717 mL 10.7434 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (13.43 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 2.5 mg/mL (13.43 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.98%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 5.3717 mL 26.8586 mL 53.7172 mL 134.2931 mL
    5 mM 1.0743 mL 5.3717 mL 10.7434 mL 26.8586 mL
    10 mM 0.5372 mL 2.6859 mL 5.3717 mL 13.4293 mL
    15 mM 0.3581 mL 1.7906 mL 3.5811 mL 8.9529 mL
    20 mM 0.2686 mL 1.3429 mL 2.6859 mL 6.7147 mL
    25 mM 0.2149 mL 1.0743 mL 2.1487 mL 5.3717 mL
    30 mM 0.1791 mL 0.8953 mL 1.7906 mL 4.4764 mL
    40 mM 0.1343 mL 0.6715 mL 1.3429 mL 3.3573 mL
    50 mM 0.1074 mL 0.5372 mL 1.0743 mL 2.6859 mL
    60 mM 0.0895 mL 0.4476 mL 0.8953 mL 2.2382 mL
    80 mM 0.0671 mL 0.3357 mL 0.6715 mL 1.6787 mL
    100 mM 0.0537 mL 0.2686 mL 0.5372 mL 1.3429 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Angelicin
    Cat. No.:
    HY-N0763
    Quantity:
    MCE Japan Authorized Agent: